These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12595437)

  • 21. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
    Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS
    Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.
    Wizel B; Garg N; Tarleton RL
    Infect Immun; 1998 Nov; 66(11):5073-81. PubMed ID: 9784506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and role of heat-shock protein 65 (HSP65) in macrophages during Trypanosoma cruzi infection: involvement of HSP65 in prevention of apoptosis of macrophages.
    Sakai T; Hisaeda H; Ishikawa H; Maekawa Y; Zhang M; Nakao Y; Takeuchi T; Matsumoto K; Good RA; Himeno K
    Microbes Infect; 1999 May; 1(6):419-27. PubMed ID: 10602674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.
    Rodrigues MM; Ribeirão M; Pereira-Chioccola V; Renia L; Costa F
    Infect Immun; 1999 Aug; 67(8):3855-63. PubMed ID: 10417149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
    Miyahira Y
    Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn SJ
    Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
    Infect Immun; 2005 Jan; 73(1):181-92. PubMed ID: 15618153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    Ko SY; Ko HJ; Chang WS; Park SH; Kweon MN; Kang CY
    J Immunol; 2005 Sep; 175(5):3309-17. PubMed ID: 16116223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
    Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
    PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
    Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.
    Lieke T; Graefe SE; Klauenberg U; Fleischer B; Jacobs T
    Infect Immun; 2004 Dec; 72(12):6817-25. PubMed ID: 15557602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection.
    Cardillo F; Cunha FQ; Tamashiro WM; Russo M; Garcia SB; Mengel J
    Scand J Immunol; 2002 Jan; 55(1):96-104. PubMed ID: 11841697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.